News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
The addition of pembrolizumab to neoadjuvant chemotherapy in the phase III KEYNOTE-756 – European Society for Medical Oncology
Jan 29, 2025, 18:07

The addition of pembrolizumab to neoadjuvant chemotherapy in the phase III KEYNOTE-756 – European Society for Medical Oncology

ESMO – European Society for Medical Oncology shared a post on LinkedIn:

“The addition of pembrolizumab to neoadjuvant chemotherapy in the phase III KEYNOTE-756 significantly improves the pathological complete response rate in patients with high-risk, early-stage ER+/HER2− Breast Cancer.

Read the full news on ESMO Daily Reporter.”

pembrolizumab

 

Breast Cancer cancer ESMO ESMO Daily Reporter European Society for Medical Oncology fight against cancer Global fight against cancer HER2 KEYNOTE-756 neoadjuvant chemotherapy OncoDaily Oncology pembrolizumab
Special Coverage
Blog
Jun 9, 2025, 02:00
Irena Joveva: Health has no borders, and silence is not an option
Blog
Jun 9, 2025, 01:16
Wafik S. El-Deiry: Leading Discussions of our Legorreta Cancer Center Research Program Leaders
Oncolibrary
Jun 8, 2025, 17:28
ASCO 2025 Plenary Highlights: Key Practice-Changing Data Across TOP 5 ATOMIC, MATTERHORN, SERENA-6, VERIFY, and NIVOPOSTOP Trials
Blog
Jun 8, 2025, 17:04
Kimryn Rathmell Highlighted BuckeyeThon Students Raising Pediatric Blood Cancer Awareness at Farmers Market
Career
Jun 8, 2025, 17:03
Herbert Loong Joined IASLC Communications Committee For the 2025-2027 Term
Insight
Jun 8, 2025, 17:00
Christian Rolfo Highlighted VISION Trial Findings on METex14 NSCLC Detection Using Liquid and Tissue Biopsies
Blog
Jun 8, 2025, 16:58
Wafaa M Rashed: Final Words to the Eighth Cohort of the Policy Advocacy in Genetics and Genomics Course
Insight
Jun 8, 2025, 16:57
Akhil Santhosh Reflected on Experience with Dana-Farber’s Breast Oncology Team Through ASCO IDEA Program
Insight
Jun 8, 2025, 16:55
Al-Ola Abdallah Shared 2025 MIDAS Trial on MRD-Guided Myeloma Therapy Published in NEJM
Insight
Jun 8, 2025, 16:53
Talha Badar Shared an Article Published in Blood, ASH Journal
Insight
Jun 8, 2025, 16:48
Arndt Vogel Highlighted Phase II PANACHE01 Trial on Neoadjuvant FOLF(IRIN)OX for Resectable PDAC
Insight
Jun 8, 2025, 16:46
Giannis Mountzios Highlighted ASCO25 DeLLphi-304 Trial Featuring Tarlatamab Progress